M&R Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $214K | Buy |
663
+9
| +1% | +$2.94K | 0.05% | 127 |
|
|
2024
Q2 | $204K | Buy |
654
+2
| +0.3% | +$588 | 0.05% | 128 |
|
|
2024
Q1 | $186K | Sell |
652
-78
| -11% | -$22.8K | 0.05% | 134 |
|
|
2023
Q4 | $210K | Buy |
730
+127
| +21% | +$34.6K | 0.05% | 141 |
|
|
2023
Q3 | $162K | Buy |
603
+2
| +0.3% | +$499 | 0.04% | 156 |
|
|
2023
Q2 | $134K | Sell |
601
-476
| -44% | -$110K | 0.03% | 165 |
|
|
2023
Q1 | $260K | Sell |
1,077
-41
| -4% | -$10.1K | 0.07% | 124 |
|
|
2022
Q4 | $294K | Sell |
1,118
-269
| -19% | -$72.1K | 0.08% | 116 |
|
|
2022
Q3 | $312K | Buy |
1,387
+585
| +73% | +$142K | 0.09% | 103 |
|
|
2022
Q2 | $195K | Buy |
802
+245
| +44% | +$60K | 0.05% | 145 |
|
|
2022
Q1 | $134K | Buy |
557
+302
| +118% | +$69.4K | 0.03% | 176 |
|
|
2021
Q4 | $57K | Sell |
255
-225
| -47% | -$47.5K | 0.01% | 225 |
|
|
2021
Q3 | $102K | Sell |
480
-2,610
| -84% | -$601K | 0.02% | 188 |
|
|
2021
Q2 | $753K | Sell |
3,090
-85
| -3% | -$20.9K | 0.17% | 75 |
|
|
2021
Q1 | $789K | Buy |
3,175
+140
| +5% | +$33.4K | 0.2% | 72 |
|
|
2020
Q4 | $697K | Buy |
3,035
+125
| +4% | +$28.8K | 0.16% | 83 |
|
|
2020
Q3 | $739K | Buy |
2,910
+95
| +3% | +$23.5K | 0.18% | 87 |
|
|
2020
Q2 | $663K | Sell |
2,815
-1,500
| -35% | -$342K | 0.18% | 89 |
|
|
2020
Q1 | $874K | Buy |
4,315
+430
| +11% | +$93.9K | 0.26% | 77 |
|
|
2019
Q4 | $936K | Sell |
3,885
-202
| -5% | -$44.5K | 0.21% | 86 |
|
|
2019
Q3 | $790K | Sell |
4,087
-2,100
| -34% | -$403K | 0.18% | 99 |
|
|
2019
Q2 | $1.14M | Sell |
6,187
-125
| -2% | -$22.4K | 0.26% | 81 |
|
|
2019
Q1 | $1.15M | Buy |
6,312
+100
| +2% | +$19.1K | 0.26% | 79 |
|
|
2018
Q4 | $1.21M | Buy |
6,212
+287
| +5% | +$56K | 0.32% | 70 |
|
|
2018
Q3 | $1.23M | Sell |
5,925
-300
| -5% | -$59.1K | 0.27% | 78 |
|
|
2018
Q2 | $1.15M | Buy |
6,225
+1,005
| +19% | +$178K | 0.26% | 78 |
|
|
2018
Q1 | $889K | Buy |
5,220
+105
| +2% | +$19.3K | 0.21% | 90 |
|
|
2017
Q4 | $889K | Buy |
5,115
+335
| +7% | +$59.3K | 0.21% | 96 |
|
|
2017
Q3 | $891K | Buy |
4,780
+100
| +2% | +$17.7K | 0.22% | 93 |
|
|
2017
Q2 | $792K | Buy |
4,680
+1,124
| +32% | +$183K | 0.2% | 97 |
|
|
2017
Q1 | $583K | Buy |
3,556
+660
| +23% | +$110K | 0.15% | 108 |
|
|
2016
Q4 | $423K | Buy |
2,896
+200
| +7% | +$30.1K | 0.11% | 131 |
|
|
2016
Q3 | $449K | Buy |
2,696
+46
| +2% | +$7.78K | 0.13% | 122 |
|
|
2016
Q2 | $403K | Hold |
2,650
| – | – | 0.12% | 125 |
|
|
2016
Q1 | $397K | Hold |
2,650
| – | – | 0.12% | 122 |
|
|
2015
Q4 | $430K | Hold |
2,650
| – | – | 0.12% | 123 |
|
|
2015
Q3 | $367K | Hold |
2,650
| – | – | 0.1% | 133 |
|
|
2015
Q2 | $407K | Sell |
2,650
-500
| -16% | -$80.1K | 0.1% | 139 |
|
|
2015
Q1 | $504K | Buy |
3,150
+530
| +20% | +$83.5K | 0.12% | 128 |
|
|
2014
Q4 | $417K | Sell |
2,620
-500
| -16% | -$77.9K | 0.1% | 140 |
|
|
2014
Q3 | $438K | Buy |
3,120
+10
| +0.3% | +$1.31K | 0.1% | 139 |
|
|
2014
Q2 | $368K | Hold |
3,110
| – | – | 0.09% | 147 |
|
|
2014
Q1 | $384K | Buy |
3,110
+34
| +1% | +$4.12K | 0.09% | 137 |
|
|
2013
Q4 | $351 | Buy |
3,076
+66
| +2% | +$7.51K | 0.09% | 139 |
|
|
2013
Q3 | $337K | Hold |
3,010
| – | – | 0.09% | 139 |
|
|
2013
Q2 | $297K | Buy |
+3,010
| New | +$312K | 0.09% | 146 |
|
Other funds holding AMGN
M&R Capital Management's AMGN Position: Q3 2024 in Review
M&R Capital Management increased its Amgen (AMGN) stake by 1.4% in Q3 2024, buying an estimated $2.94K and bringing the position to 663 shares worth $214K. The position accounts for 0.05% of the portfolio, ranked #127.
M&R Capital Management first reported a position in AMGN in Q2 2013 and has held it in 46 quarters since. The position peaked at $1.23M in Q3 2018. 2,824 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.
- M&R Capital Management held 663 shares of Amgen worth $214K as of Q3 2024.
- M&R Capital Management bought 9 Amgen shares in Q3 2024, an estimated $2.94K.
- Amgen made up 0.05% of M&R Capital Management's portfolio in Q3 2024, its #127 holding.
- M&R Capital Management first reported a position in Amgen in Q2 2013 and has held it in 46 quarters since.
- M&R Capital Management's Amgen position peaked at $1.23M in Q3 2018.
- 2,824 funds tracked by Wall St. Rank held Amgen as of Q3 2024.
Based on M&R Capital Management's 13F filing for Q3 2024, filed 2 Oct 2024.